October 24, 2018, 8:00 AM – 4:30 PM
Harvard Law School, Wasserstein Hall, Milstein East (2036)
1585 Massachusetts Ave., Cambridge, MA
View videos of the event and the presentations made.
Join us for a one-day conference exploring the current pharmaceutical pricing landscape. This event will bring together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants will assess the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We will also explore and articulate best practices to expand access to medicines and develop a plan for disseminating these practices more widely.
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University.
Agenda
8:00 – 8:30am, Registration
8:30 – 8:45am, Welcome Remarks
- I. Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law and Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School
- Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University
8:45 – 9:30am, Keynote Address
- Ronald Piervincenzi, CEO, United States Pharmacopeial Convention
9:30 – 10:45am, Panel I: From Development to Delivery in the United States
- Peter B. Bach, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
- Surya Singh, Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health
- Michael Caljouw, Vice President, State Government and Regulatory Affairs, Blue Cross Blue Shield of Massachusetts
- Moderator: Carmel Shachar, Executive Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and Lecturer at Law, Harvard Law School
10:45 – 11:00am, Break
11:00 am – 12:15 pm, Panel II: From Development to Delivery Globally
- Amy Flood, Senior Vice President, Public Affairs, Gilead Sciences, Inc.
- Lauren Galinsky, PIH’s Senior Clinical Operations Advisor, Partners in Health
- Hannah Kettler, Senior Program Officer on the Life Sciences Partnerships team at the Bill and Melinda Gates Foundation
- Moderator: Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University
12:15 – 12:45pm, Keynote Address
- Joe Grogan, Associate Director, Health Programs, Office of Management and Budget
12:45 – 1:45pm, Networking Lunch
1:45 – 3:00pm, Panel III: Best Practices in Pricing Policy for Essential Drugs
- Peter B. Bach, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
- Annette Gaudino, HIV/HCV Project Co-Director, Treatment Action Group (TAG)
- Aaron S. Kesselheim, Director, Program on Regulation, Therapeutics, and Law (PORTAL), Brigham & Women’s Hospital, and Associate Professor of Medicine, Harvard Medical School
- Jami Taylor, Managing Director, Stanton Park Capital
- Moderator: William W. Fisher, WilmerHale Professor of Intellectual Property Law, Harvard Law School, and Faculty Director, Berkman Klein Center for Internet and Society at Harvard University
3:00 – 3:15pm, Break
3:15 – 4.30 pm, Panel IV: Innovations in Drug Discovery and Policy: From Bitter Pills to Artificial Intelligence
- Sara Gerke, Research Fellow in Precision Medicine, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School
- Muhammad Zaman, Howard Hughes Medical Institute Professor of Biomedical Engineering and International Health at Boston University
- Moderator: Ashveena Gajeelee, Research Fellow, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, and the Harvard Health Law Society, with support from Gilead Sciences, Inc.